SARS-CoV2 Testing in Long Term Care Centers

Nursing Home populations are at high risk for infection and seri- ous illness including death from COVID-19. The only approved test for identification of those in the acute phase of infection is the reverse transcription-polymerase chain reaction (rt-PCR).

Key Highlights of LongTerm Care SARSCoV2 Program

• Facility wide testing of all residents should be considered in facilities with suspected or confirmed cases of SARS-CoV2. Testing should be used to lead to specific infection prevention and control interventions (IPC)

• Separation of those with SARS-CoV-2 infection from those without detectable infection
• Testing of healthcare providers should be considered in facilities with suspected or confirmed cases of

SARS-CoV2
• Identification of healthcare providers with SARS-CoV2 infection for work exclusion

Repeat Testing Considerations

  • Retest any resident that develops symptoms consistent with SARS-CoV2
  • Retest residents that frequently leave the facility for dialysis or other services that are known to ex- pose residents to those with possible infection
  • Retest healthcare providers who develop symptoms consistent with SARS-CoV2
  • Consider retesting healthcare providers at a predetermined frequency if community prevalence of infections is high.

References:
Centers for Disease Control Guidelines Published April 30, 2020 https://www.cdc.gov/coronavirus/2019-ncov/hcp/nursing-homes-

Share This Post

Share on facebook
Share on linkedin
Share on twitter
Share on email

More To Explore

Testing Info

Molecular Diagnosis of Wound Infections

Problem Chronic, non-healing wounds such as diabetic foot ulcers and venous stasis ulcers are often infected with a polymicrobial biofilm Traditional microbiology culture fails to

Testing Info

Molecular Diagnosis of Urinary Tract Infections

Do you see negative urine culture results in patient’s with an obvious infection? Do you get culture reports described as a mixed flora? Problem Urinary